methotrexate has been researched along with Epiretinal Membrane in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Arroyo, JG; Lemire, CA; Ralph, A; Seto, B | 1 |
Arrow, SS; Felis, SC; Hillenmayer, A; Koenig, SF; Strehle, LD; Vounotrypidis, E; Wertheimer, CM; Wolf, A | 1 |
Amarnani, D; Arboleda-Velasquez, JF; Eliott, D; Kim, LA; Machuca-Parra, AI; Marko, CK; Stefater, JA; Stryjewski, TP; Wong, LL | 1 |
Koop, A; Ossewaarde, A; Rothova, A | 1 |
1 review(s) available for methotrexate and Epiretinal Membrane
Article | Year |
---|---|
Peripheral multifocal chorioretinitis: complications, prognosis and relation with sarcoidosis.
Topics: Chorioretinitis; Drug Therapy, Combination; Epiretinal Membrane; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Macular Edema; Methotrexate; Prognosis; Sarcoidosis | 2013 |
3 other study(ies) available for methotrexate and Epiretinal Membrane
Article | Year |
---|---|
Intravitreal Methotrexate for Recalcitrant Epiretinal Membrane Reproliferation.
Topics: Aged; Epiretinal Membrane; Female; Humans; Methotrexate; Retrospective Studies; Tomography, Optical Coherence; Vitrectomy | 2022 |
Inhibition of proliferative vitreoretinopathy by a newly developed methotrexate loaded drug carrier in vitro.
Topics: Bromodeoxyuridine; Epiretinal Membrane; Humans; Methotrexate; Retinal Detachment; Vitrectomy; Vitreoretinopathy, Proliferative | 2023 |
Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
Topics: Adult; Aged; Apoptosis; Biomarkers; Cell Culture Techniques; Cell Movement; Cell Proliferation; Cell Separation; Epiretinal Membrane; Extracellular Matrix Proteins; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Models, Biological; Phenotype; Retinal Detachment; Retinal Pigment Epithelium; Tumor Necrosis Factor-alpha; Vitreoretinopathy, Proliferative | 2017 |